Axoft reports early human recordings with its soft Fleuron brain probes
The company says short-term recordings in 12 surgical patients in Boston and Panama showed stable, high-yield signals, presented at three fall neuroscience meetings.
News
The developments that matter in BCIs and neurotechnology, with context and links to the original sources.
The company says short-term recordings in 12 surgical patients in Boston and Panama showed stable, high-yield signals, presented at three fall neuroscience meetings.
The Series D, reportedly at a $3.5 billion valuation, funds PRIMA's wider European rollout, a planned US launch through the FDA's Humanitarian Device Exemption and Science's biohybrid brain interface program.
The 673-person HOPE study of 40 Hz light and sound stimulation did not beat sham overall; Cognito points to a pre-specified mild-disease subgroup and plans to talk to the FDA.
Participants with high-level paralysis are using the Shanghai company's fully implanted BCI for travel, shopping, home and social tasks in a purpose-built test space.
At the Society for Neuroscience meeting in Washington, D.C., researchers presented an expressive synthetic-voice BCI, a year of independent communication by a completely locked-in person, and a brain-to-text system running on an iPhone.
The brain-computer interface company and the ALS nonprofit will set up a structured way for people with ALS and their caregivers to give feedback on Precision's Layer 7 system while it is in development.
At a November 13 briefing, Minhang district announced a dedicated brain-computer interface industry fund, and city officials gave new figures on Shanghai's BCI sector.
A remote, DTRA-funded study of 541 adults compared electroCore's handheld nerve stimulator, a sound-based therapy, both, or monitoring alone. All active arms improved, but none beat the others.
MIIT's fifth 2026 batch of industry standard projects includes nine BCI standards covering product grading, risk management, implant wireless links and data and algorithm management.
The endovascular BCI company stopped recruiting in its US, Australian and Canadian studies after a performance issue with the implant's lead, and is restructuring around a new San Diego team.
A Spanish-Belgian pilot study in Frontiers in Neurology used a modified Cochlear implant to stimulate the inner-ear balance system; the authors call the results exploratory.
The BCI Pioneers Coalition's 13-page "OUR BCI" document asks for ongoing consent, fair pay, control over neural data and support after trials end.
The Suzhou company, which stimulates the visual cortex to create images, reports seven early human experiments with no serious adverse events.
The new US study plans to implant up to 10 adults with spinal cord injury, ALS or chronic ischemic stroke and test computer control with the N1 implant.
The NeuroStar TMS maker sold 18.75 million shares at $1.60, partly to meet a loan amendment it says would resolve its going-concern risk.
Third-quarter sales of the pediatric abdominal pain neuromodulation device reached about $2.0 million, helped by a new procedure code and wider insurance coverage. Losses also grew.
The plan for 2026 to 2030 promises full-lifecycle oversight, pre-market guidance and a standards system for brain-computer interface medical devices.
A study combining a non-invasive BCI, spinal cord stimulation and an exoskeleton for chronic stroke completed filing under China's State Council Order No. 818 on November 4.
A preliminary SEC prospectus filed on November 6 describes an actively managed ARK fund that would invest in BCI and surgical robotics companies, including possibly private ones.
Starting January 1, 2027, the temporary status adds separate device payment for outpatient implants of the nerve stimulation system, the company says.
The CHOICE study will compare the company's augmented-reality headset with eye-tracking tablets over 12 weeks in 30 adults with ALS.
The nerve stimulation company reported $9.7 million in third-quarter sales, now expects $39 million to $42 million for 2026, and has asked the FDA to clear Quell for chemotherapy-related nerve pain.
Clinic revenue drove the third quarter, while NeuroStar system sales were nearly flat. A 510(k) for a condensed treatment schedule was filed in August.
A yearlong Science review of 57 consumer EEG companies' privacy policies found that firms building brain foundation models rarely told users their recordings were used for AI training.
The Shanghai start-up has now raised about RMB 800 million in under three months, though no human implant has been reported.
A founding partner told Bloomberg the device could reach the market in two to three years, starting in China. BrainCo has not published data or named a stimulation target.
The point-of-care EEG company reported $29.3 million in third-quarter revenue and 747 active accounts, along with a new FDA 510(k) clearance for EEG trending and analysis software.
The Hangzhou chip and implant developer's second round of 2026 brings its total to RMB 1 billion. Three people have received its 320-channel retinal interface in clinical trials.
The company's third-quarter update also reported €2.5 million in revenue, 88 ARC-EX systems sold or supplied, and first implants in two smaller ARC-IM feasibility studies.
The Shanghai implant maker has registered for pre-listing tutoring with Huatai United Securities, which is an early step and not yet a listing application.
A Phase 1 study funded by the Focused Ultrasound Foundation is enrolling up to 12 people with persistent auditory hallucinations, comparing five active and five sham sessions.
The year-old Chinese BCI start-up's angel+ round was led by Shunwei Capital, with Hillhouse and robot maker AgiBot joining. Its work is still preclinical.
A Centre for Future Generations paper co-authored with RAND Europe finds no consumer BCI yet enhances people beyond normal abilities and makes nine recommendations, starting with regulating by use case.
The Stanford Digital Brain Project aims to collect about 14,000 hours of 7-tesla fMRI and wearable MEG data from roughly 100 people, and to share the data and models with researchers worldwide.
A graded hydrogel electrode from Guangxi University and Tsinghua University recorded for more than 8 hours during daily activities, with typing accuracy above 94% in eight volunteers.
The expanded clearance lowers the Minder system's minimum age from 18 to 12, giving teenagers access to continuous EEG recorded outside the hospital.
Chinese state media say a non-invasive focused ultrasound device from the Shenzhen Institutes of Advanced Technology improved conscious behavior in 13 of 24 patients. No paper has been published.
In Nature Sensors, an MIT-led team compared sesame-seed-sized magnets with implanted and skin-surface electrodes on a virtual prosthesis-control task.
Boston Scientific's recall covers 134 units of the therapy disc used with the Nalu neurostimulation system. A failed disc can leave the implant unable to deliver therapy if no backup is available.
In a 72-hour sprint at a trial participant's home, Neuralink engineers built prototype features that route decoded speech into iPhone calls, the keyboard and an AI agent.
A two-year agreement with Cleveland Clinic Abu Dhabi will study the Layer 7 cortical interface, with an early focus on people with severe paralysis.
The Los Angeles company will use its Series A to run a pivotal trial of Rhyvive, which stimulates the median nerve to reduce arrhythmia after ablation, and to prepare an FDA De Novo request.
The Michigan company plans to finish feasibility studies, seek FDA permission for US clinical studies and begin developing a fully implantable version of its RESTORE system.
In nine people with drug-resistant epilepsy, short bouts of thalamic stimulation changed brain connectivity within 18 minutes, a possible early signal for tuning DBS settings.
In a social media post, Neuralink reported 75 words per minute with a 5.8% word error rate in a participant's first week. No paper or detailed data has been released.
The Shanghai company's Series B will fund a multicenter registration trial, a mass-production plant and speech and vision BCIs.
Formerly Dandelion Science, the Boston and Geneva company led by Adam Hanina and EPFL's Martin Schrimpf aims to design neural stimulation computationally.
The Shanghai company also reports raising about RMB 1.4 billion since the start of the second half of 2026. The figures are company-reported, and no enrollment number or trial results were given.
electroCore reports results from a 50-person, sham-controlled US Air Force Research Laboratory fMRI study of noninvasive neck vagus nerve stimulation during image-analysis training.
BrainsWay reports that medical policies covering its Deep TMS treatment for obsessive-compulsive disorder now reach more than 118 million Americans.
A protocol change drops the rule that Connect-One participants must live within a four-hour drive of a study site.
Beijing's Xuanwu Hospital reported that the man who received the first NEO wireless epidural brain-computer interface in October 2023 can now hold a cup and drink on his own.
A 66-year-old woman blinded by retinitis pigmentosa can now recognize simple characters and pick up objects about two months after receiving a 320-resolution implant under the macula in a clinical trial, Chinese media report.
EPFL engineers describe LogSync, a 4 × 2 mm neural chip that measures how brain regions oscillate together and could trigger stimulation in future closed-loop psychiatric implants.
Eleven people with focal hand dystonia improved on rating scales after a targeted lesion in the motor thalamus, though side effects were common and persisted in two.
In 531 people with drug-resistant epilepsy across 16 countries, median seizure frequency fell 76% after three years of vagus nerve stimulation, according to an observational study in Neuromodulation.
The EEG company says the deal more than doubles its patient reach and gives it a route to bring EEG-based home sleep tests to patients from 2027.
In a study in the journal Brain, about one in three of 41 clinically unresponsive patients with acute brain injury changed a tone's pitch by attempting hand movements, a first step toward letting hidden-aware patients communicate.
eSonic signed a cooperation agreement in Beijing with researchers from Mickael Tanter's Paris team to adapt its ultrafast ultrasound system for brain-computer interfaces.
The Neuroscience Advancement and Innovation Nexus will work on science, tools and regulatory approaches for brain and nervous system products, starting with Alzheimer's prevention trials.
A proposed rule under the COINS Act adds biotechnology to US outbound investment controls and would prohibit most new US investment in BCI developers tied to China and other countries of concern.
An October 21 document from the offices of the Communist Party Central Committee and the State Council calls for faster commercialization of BCIs and other frontier technologies.
Founders Fund and the OpenAI Startup Fund co-led the Series A, which will fund a first long-term human trial in glioblastoma.
A manufacturing change at a supplier can cause unintended stimulation during charging or leave an implant unable to charge. Saluda reports 26 complaints among about 3,900 implanted devices that may be affected.
The company disclosed a single case at a Shenzhen conference, with a left-hand motor score rising from 0 to 14. No published paper was cited.
The NMPA approved an auditory brainstem implant from a Shanghai Ninth People's Hospital team for young children with severe inner ear malformations who cannot use a cochlear implant.
An NYU Langone pilot in 10 people found that 10 minutes of transcranial ultrasound to the globus pallidus interna reduced delusion scores for up to a week compared with sham.
Two people with upper-limb loss in Melbourne have received the Phantom X implant, which turns muscle signals in the residual limb into wireless commands for a prosthetic hand.
In a three-country randomized trial of 109 adults, people completed home tDCS sessions as planned, but depression scores improved about as much in the control group.
The China-led standard sets out a common description of what a BCI is, how it is used, what it does and how it is built.
The two companies will build an MRI and CT workflow that covers BCI patients from candidacy and surgical planning through post-implant checks, starting with speech-motor areas.
The AAO-HNSF's revised tinnitus guideline includes a new statement on bimodal neuromodulation, and Neuromod says its Lenire device is now listed as a treatment option. The guideline recommends against routine rTMS.
The randomized DETECT study is testing whether the under-the-scalp Minder system improves care decisions for people with drug-resistant epilepsy.
Up to 12 people already scheduled for DBS for Parkinson's disease or essential tremor will receive the experimental HDBS microelectrodes in an early feasibility study.
The brain-computer interface company also hired former Nevro market-access lead Katherine Neuenfeldt as senior vice president of commercial strategies, as it prepares for a permanent implant.
Dutch company Salvia BioElectronics has started RECLAIM-II, a randomized, double-blind US study of its ultra-thin MySalvia scalp implants for hard-to-treat migraine, with plans to enroll 150 people.
Researchers from Salience TMS and Ampa report response and remission rates after 20 short TMS sessions in one day, but the study had no control group.
UC San Diego researchers used light to activate a small set of motor cortex cells and recalled the wider activity pattern of a learned skill.
The new adult and pediatric processors bring AI-based sound processing and sound localization across two devices. They are not yet FDA-cleared.
The BTSEE study will test cortical stimulation guided by each patient's own brain signals in 45 children and adults with drug-resistant focal epilepsy.
Munich-based CereGate, which builds brain-computer interface software that runs on deep brain stimulation systems, closed a Series C round to fund clinical work on freezing of gait in Parkinson's disease. The amount was not disclosed.
The state's Life Science Hub will work with Cognito, Brown University and local health systems to study and deploy the company's Spectris sensory stimulation platform for Alzheimer's disease.
Mount Sinai-led researchers found that sustained improvement after subcallosal cingulate deep brain stimulation tracked with stimulation of three white matter tracts.
In a 13-patient Nature Medicine study, people in an epilepsy monitoring unit used a smartphone app with an AI chat agent to ask about their EEG data, log symptoms and flag false seizure alarms.
Three-year data from the European PRIMAvera trial, presented at AAO 2026, show a mean gain of about 30 letters, with most serious adverse events in the first six months.
A man with the inherited eye disease received the chip in Sydney in May and has begun reading letters and a word in rehabilitation, the company says.
The PULSAR feasibility study, running under an FDA investigational device exemption, plans to enroll up to 30 adults whose asthma stays uncontrolled despite medication.
The wristband delivers rhythmic stimulation to the median nerve, an approach studied for reducing tics in Tourette syndrome. A medical version is still in regulatory review.
The start-up, backed by Khosla Ventures and Accel, says sensors hidden in an ordinary-looking cap can pick up brain signals through hair. It has not published performance data.
In GenSight's phase 1 PIONEER trial, a one-time gene injection plus light-projecting goggles improved light sensitivity or object detection in some people with advanced retinitis pigmentosa.
The company says two sheep implanted with its cortical modules showed stable signal quality and decoding for more than four years, with no array migration.
A preprint pools surface recordings from 70 patients at 12 medical centers, covering cortex, brainstem and spinal cord, as the company's implant count passes 100.
A report to the General Assembly recommends prohibiting forced use of brain-based tools by police, courts and prisons and treating neural data as highly sensitive. It is not binding.
Founded by former Forest Neurotech co-founder Will Biederman, the start-up is backed by General Catalyst, has licensed Butterfly Network's ultrasound chips and is enrolling its first human study.
The Imperial College London spinout, which already supplies Motif Neurotech, will use the round led by Odyssey Ventures to launch products and expand in the US.
A 10-patient safety study at MD Anderson will test the noninvasive device in people with pancreatic cancer and cachexia.
In 343 patients at 10 centers, GBA1 carriers who received DBS later in their disease declined faster cognitively than carriers treated earlier.
Drawing on 16 neurotech companies in six countries, the OECD says a single rule for all neurodata is unlikely to work.
The CAP24 lead lets surgeons use Saluda's Evoke closed-loop spinal cord stimulation with a paddle electrode.
The STROKE-REWIRE study will test a wireless, battery-free implant that pairs vagus nerve stimulation with arm rehabilitation in up to 135 people with chronic stroke.
Karl Deisseroth, Peter Hegemann and Georg Nagel share the prize for the light-sensitive proteins that let scientists switch individual nerve cells on and off.
The AMA CPT Editorial Panel approved a Category I code for subfascial implantation of a tibial neuromodulation device, effective January 1, 2028.
An LMU Munich study used transcranial temporal interference stimulation in healthy volunteers and saw changes in effort-based decisions and striatal activity.
The Boston company's new brain-sensing headphones track focus and fatigue and store a running history of the wearer's brain activity.
Self-supervised models trained on participants' own unlabeled recordings kept cursor decoders usable for weeks, and one participant reached 11.32 bits per second, the company reports.
The ADVENT study will compare adaptive and conventional DBS in 104 people with Parkinson's disease across the US and Europe.
The Series D values the maker of the Layer 7 Cortical Interface at about $1 billion and brings its total funding to $430 million.
HongShan and Yunqi led the Pre-A round for the Shanghai start-up, which pairs ultrasound stimulation with multimodal brain readouts.
After stroke rehabilitation, the implant is now recognized for helping people with quadriplegia control a computer cursor with brain signals.
A participant with ALS used the N1 implant to generate synthesized speech in a voice rebuilt from earlier recordings. No peer-reviewed data has been published.
Co-founded by Nicholas Schiff, the company targets the central thalamus in chronic moderate-to-severe traumatic brain injury.
Neuracle seeks about $345 million on Shanghai's STAR Market; BrainCo has filed in Hong Kong; none has priced yet.
Three months after implantation, the Connexus BCI let a woman with motor neuron disease answer open-ended questions and talk with her grandchildren.
Edward Chang's team decoded concurrent speech and upper-body gestures, a step toward more natural, expressive communication BCIs.
Quicktome DB automatically localizes DBS leads, segments deep structures and maps each patient's brain connectivity.
The NSCEB calls for clearer FDA pathways, Medicare coverage, shared neural data infrastructure and better federal coordination for BCIs.
Sam Altman's BCI start-up will use Butterfly's Ultrasound-on-Chip technology under an exclusive multi-year license to build ultrasound-based brain interfaces.
A secondary analysis of 89 patients found faster improvement with BrainsWay's accelerated SWIFT protocol than with standard daily sessions.
The Chengdu-based start-up, co-founded by Shanda Group's Tianqiao Chen, raised two rounds in six months to build non-invasive 'read and write' BCIs.
The study expansion moves the Connexus implant beyond lab equipment toward everyday home use.
The Ackman Oxman Institute will focus on brain research, rehabilitation and longevity, with Mount Sinai as a clinical partner.
The platform tracks tremor, slowness of movement, dyskinesia, sleep and medication use to support clinical care.
NeuroQuant PET quantifies amyloid and other tracer uptake to help assess cognitive impairment, including Alzheimer's disease.
Its REMI stick-on sensors let people record EEG at home for weeks; the company holds five FDA clearances.
Founded by Chad Bouton, the company launches stimulation and BCI products after Nature Medicine results in a man with complete paralysis.
The wireless retinal chip, approved for vision loss from geographic atrophy, can now be sold across 30 European countries; US approval is still pending.
In an intraoperative study at TU Munich, the start-up's batteryless BCI technology captured brain signals from patients undergoing brain tumor surgery.
Feinstein Institutes researchers combined a brain implant with spinal and sensory-cortex stimulation to restore arm and hand movement and a sense of touch.
Descartes, trained on 250,000 hours of brain data, analyzes 15 minutes of dry-EEG recordings, starting with PTSD diagnosis.
AlphaDBS continuously senses brain signals and adjusts stimulation automatically for Parkinson's disease.
Shanghai's Huashan Hospital implanted Neuracle's NEO, the first invasive BCI cleared for sale anywhere, in a man with tetraplegia.
The UB ERP system records task-based EEG responses with dry electrodes and produces results in under five minutes.
At Royal Melbourne Hospital, the Cipher interface was placed for 30 minutes during tumor surgery in three people, a first step toward a glioblastoma therapy.
In 54 patients, staged bilateral treatment improved core motor symptoms by 32% and motor complications by 67%, with benefits lasting over two years.
Surgeons at University of Michigan Health implanted the wireless device in a woman with motor neuron disease, starting the six-year Connect-One study.
Reports say Samsung Foundry is producing a 4-nanometer, fourth-generation Neuralink chip designed to both read and stimulate the brain.
In Nature Medicine, UC Davis researchers report 99% word accuracy and more than 3,800 hours of home use, including for work, without researchers present.
MeRT tailors TMS treatment to each patient's EEG; clearance followed a randomized, double-blind multisite trial.
Using real-time fMRI, researchers showed people learn a brain-computer interface much faster when it is matched to each person's existing patterns of brain activity.
The two-year-old company, valued at $2.5 billion, uses connectomics to try to reverse-engineer the brain and build far more efficient AI.
RELIEV-CM2 enrolled 300 people with chronic migraine across 28 sites; five new billing codes take effect in 2027.
ECoG Assistant flags important intracranial EEG recordings from the RNS System, built on more than 124,000 expert-labeled records.
Its FDA-cleared Quicktome maps each patient's brain networks; a new CPT code creates a US reimbursement route.
The Dutch-approved study at UMC Utrecht will test a fully implanted, battery-free wireless ECoG BCI for communication at home.
The FDA clearance covers compressed rTMS and theta-burst schedules that finish treatment in days rather than weeks.
The headset stimulates the vestibular nerve behind the ear; 66% of 383 trial participants had a meaningful drop in PTSD symptoms at 12 weeks.
SPR's SPRINT PNS is a 60-day peripheral nerve stimulation therapy for pain that doesn't require a permanent implant.
The Geneva start-up builds ultra-soft implants aiming for full-cortex coverage, and works with Science Corp.'s BCI platform.
H.814 recognizes mental and neural data privacy and freedom of thought, and limits how neurotechnology can access or alter brain activity.
Revi is implanted near the ankle with no internal battery and powered by a wearable; three-year data showed lasting benefit.
The company formerly known as MicroTransponder sells the only FDA-approved implant designed to improve arm function after chronic ischemic stroke.
Noctrix's Nidra is a wearable that uses nerve stimulation at the lower leg to ease restless legs symptoms and improve sleep.
The Series A, led by C.P. Group Innovation, funds global trials and manufacturing of its Fleuron-based implantable BCI.
The same fully implanted Brain Interchange device used to stimulate the brain for stroke recovery also decoded the participant's intentions to control a computer.
The RESONATE study will test Motif's wirelessly powered stimulator, which sits in the skull above the brain, in people with treatment-resistant depression.
The Los Angeles company's platform combines stimulation with real-time physiological feedback to personalize pain therapy.
In a University of Manchester study during brain tumor surgery, the graphene array recorded high-resolution signals with no device-related adverse events.
The updated wearable adds new therapy modes and adaptive calibration for hand tremor in essential tremor and Parkinson's disease.
The pea-sized, 520-electrode sensor will first be tested in stroke patients during surgery; a later version would add lab-grown neurons.
The San Francisco start-up, led by former iota Biosciences CEO Michel Maharbiz, pairs a brain interface with a motorized glove to help stroke survivors regain hand function.
The six-electrode hypoglossal nerve system activates airway muscles; 65% of patients responded at 12 months in the OSPREY trial.
In Nature Neuroscience, a BCI that maps attempted finger movements to a QWERTY keyboard reached able-bodied-level accuracy for one user at home.
The NMPA granted Class III approval for the implant, which restores basic hand grasp for people with cervical spinal cord injury.
The Smart Neurostimulation System targets memory problems after traumatic brain injury, stimulating only when encoding is likely to fail.
StairMed's 256-channel wireless BCI and surgical robot are heading into multi-site registration trials of about 40 patients in 2026.
The Occular system pairs a headset camera with a brain implant to target blindness that retinal implants can't treat.
Its Spectris headset delivers 40 Hz light and sound stimulation at home; the fully enrolled HOPE study is due to read out this year.
In 128 implanted patients, 94% of responders cut urgent leakage episodes by at least half, with no serious device-related events.
The Series C values the company at about $1.5 billion and funds PRIMA's launch plus new clinical programs.
The FDA clearance covers adults with major depression who haven't responded to medication; the system emphasizes portability and continuous operation.
Worn on the temple, the device tracks cerebral blood flow for focus and fatigue insights, starting with elite athletes.
In a multi-year deal, Swiss start-up Neurosoft will build on Science's clinical-grade neural recording tools, which the companies say cuts the cost of first-in-human trials.
In 62 chronic stroke survivors, 55.5% of those using the EEG-based BCI had clinically meaningful recovery versus 9.6% of controls.
The Irish company's NEUROMARK system disables overactive nasal nerves using impedance-controlled radiofrequency energy.
The start-up says its organic computing platform made a video AI model 23 times more efficient.
The surgery at Harborview Medical Center in Seattle continues an NIH-funded study of closed-loop brain stimulation for arm recovery.
Nine engineers, including BrainGate's John Donoghue and .NeuroRestore's Courtine and Bloch, were honored for neural interface technologies.
The deal, reported at close to $2 billion, brings technology that reads whispered or mouthed words from subtle facial muscle movements.
All six blind participants performed better on visual tasks with the device on, and fewer than 4% of electrodes failed over the study.
The company's participant count has nearly doubled since September 2025, with studies spanning cursor control, robotic arms, speech and vision.
OpenAI is the largest investor in the seed round, led by Bain Capital. The start-up is betting on ultrasound and molecular tools instead of electrodes.
A UCSF and Attune Neurosciences preprint reports low-intensity ultrasound to the striatum was safe and eased hallucination severity.
The funds support RESTORE, which pairs deep brain stimulation with rehabilitation for people with lasting arm weakness after stroke.
Valencia's eCoin stimulates the tibial nerve near the ankle to treat urge urinary incontinence.
Proliv Rx stimulates the occipital and trigeminal nerves at home for adults whose depression hasn't responded well enough to antidepressants.
The companies will integrate Precision's Layer 7 surface interface with Medtronic's StealthStation for real-time brain mapping during surgery.
The Series A funds a pulmonary neuromodulation system that targets the airway nerves involved in asthma symptoms.
The company will use its existing rapid-EEG headband with a new algorithm to spot large vessel occlusion strokes in hospitalized patients.
In Brain Stimulation, the company reports stable decoding and stimulation over months, a step toward human trials for memory loss after brain injury.
The Series A, led by Spectrum Moonshot Fund, brings the Boston company's total funding to $65 million.
The new company will pair low-intensity focused ultrasound with drugs, starting with brain tumors including glioblastoma.
MyoRegulator uses multi-site direct current stimulation aimed at slowing the loss of function in ALS.
The seed round, led by Future Ventures, backs flexible carbon-based fibers designed to reach deep targets without open surgery.
The FL-100 tDCS headset can be prescribed for moderate to severe major depression, alone or alongside medication, with US launch expected in 2026.
Astera Neuro will spend more than $600 million over a decade studying how the brain produces cognition and conscious experience.
David McMullen, who directed the FDA office overseeing neurological devices including BCIs, joins the company in late December.
The wireless brain interface, described in Nature Electronics, streams data at 100 Mbps and is entering short intraoperative human studies.
Deep brain stimulation for dystonia moves from humanitarian exemption to full effectiveness labeling, including patients 12 and older.
The Sydney company's Evoke system adjusts every stimulation pulse based on the spinal cord's measured response.
The FDA clearance lets BrainWatch, with Persyst AI software, flag continuous seizure activity in emergency and community hospitals.
In a three-person FDA early feasibility study, all participants improved and two reached remission, according to the company.
The EVIDENT program aims to replace trial-and-error psychiatric care with quantitative data, including for neuromodulation therapies.
The Connexus high-data-rate implant can now begin a clinical study in people who have lost the ability to speak.
The Delphi-MD system stimulates the brain with magnetic pulses and records the response with EEG to benchmark brain health.
FUSMobile's Neurolyser XR uses X-ray-guided ultrasound to heat and disable pain-sensing nerves in spinal facet joints, without incisions.
The Series B backs Beacon's FDA-cleared Waveband headband and a growing neurodiagnostic dataset for drug trials.
The FDA clearance for adolescent depression as an add-on therapy was based on real-world data from more than 1,100 young patients.
The Magstim Rapid can now be used on peripheral nerves for chronic, post-traumatic and post-surgical pain, with no implant or drugs.
The Boston start-up uses light-sensitive proteins to switch neurons on and off, starting with trigeminal pain.
The Google X spin-out's Smartbuds track sleep with in-ear EEG and play sounds timed to deepen slow-wave sleep.
The Barcelona company will use Microsoft's Azure AI tools to make its neural platform learn and adapt to each patient's brain signals.
The EASEE system stimulates the brain from beneath the scalp, without touching the brain, for people with drug-resistant focal epilepsy.
The Series D funds the study Synchron needs before it can ask the FDA for full market approval of the Stentrode.
The mission-driven fund, co-founded by the Reeve Foundation, Wings for Life and Spinal Research, brings patient and clinical networks as well as capital.
All 194 member states approved a Recommendation that protects mental privacy and neural data and limits uses on children, at work and in consumer products.
The MOTE device, about 300 microns long, is powered by light and sends neural signals back as infrared pulses.
The Houston institute brings together Rice's neuroengineering, neuroscience and brain-and-society programs with Texas Medical Center partners.
Published in Cephalalgia, real-world data show treating within an hour of onset nearly doubled the chance of pain relief with Nerivio.
A man with motor neuron disease was implanted at University College London Hospitals as part of the GB-PRIME study.
The bimodal neuromodulation device, already FDA-authorized, now meets the EU's stricter device rules and a multi-country quality audit.
Prosthetics maker Ottobock anchored the private placement, which funds the implantable ARC-IM program and ARC-EX sales.
A Journal of Neural Engineering study in one person with ALS is the first demonstration of an eye-movement BCI using endovascular recordings.
The company's FDA-cleared Ampa One is designed to bring transcranial magnetic stimulation to more clinics; it is also developing a one-day protocol.
The London start-up uses laser light through a forehead sensor to track brain blood flow and other measures in intensive care and surgery.
In the PRIMAvera trial, 81% of participants had a meaningful gain in visual acuity at one year with Science Corp.'s PRIMA system.
The deal adds Nalu's miniature, battery-free peripheral nerve stimulator for chronic pain to Boston Scientific's neuromodulation business.
The MHRA plans reliance routes from 2027 for devices cleared via FDA 510(k), De Novo and PMA, which could speed UK access to neurotech.
Published in Brain Stimulation, the work found the non-invasive therapy affects the same thalamic region targeted by deep brain stimulation.
The preprint introduces SONIC, a way to measure how much information a brain interface can transmit, and reports record throughput in sheep.
In Nature Biomedical Engineering, the company reports high-bandwidth recording and stimulation through a sub-millimeter slit in the skull, without open surgery.
The non-invasive trial tests whether brain signals, eye gaze and AI can help people with ALS, stroke or spinal cord injury communicate.
The bill would have the FTC review how brain and nervous-system data is collected and used, as more states pass their own neural privacy laws.
The EMG wristband that ships with Meta Ray-Ban Display glasses reads muscle signals to turn tiny finger movements into commands.
No stories with that tag yet.
Prefer a feed? Subscribe via RSS.